1) Wyse E,
Handa JT,
Friedman AD,
Pearl MS.
A review of the literature for intra-arterial chemotherapy used to treat retinoblastoma.
Pediatr Radiol.
2016 Aug;46(9):1223-33.
doi: 10.1007/s00247-016-3554-6.
Epub 2016 Feb 17.
Review.
PubMed PMID: 26886915.
2) Vijayakrishnan R,
Shields CL,
Ramasubramanian A,
Emrich J,
Rosenwasser R,
Shields JA.
Irradiation toxic effects during intra-arterial chemotherapy for retinoblastoma: should we be concerned? Arch Ophthalmol.
2010 Nov;128(11):1427-31.
doi: 10.1001/archophthalmol.2010.258.
PubMed PMID: 21060044.
3) Gobin YP,
Rosenstein LM,
Marr BP,
Brodie SE,
Abramson DH.
Radiation exposure during intra-arterial chemotherapy for retinoblastoma.
Arch Ophthalmol.
2012 Mar;130(3):403-4; author reply 404-5.
doi: 10.1001/archopthalmol.2011.2717.
PubMed PMID: 22411679.
4) Vijayakrishnan R,
Shields CL,
Ramasubramanian A,
Emrich J,
Rosenwasser R,
Shields JA.
Irradiation toxic effects during intra-arterial chemotherapy for retinoblastoma: should we be concerned? Arch Ophthalmol.
2010 Nov;128(11):1427-31.
doi: 10.1001/archophthalmol.2010.258.
PubMed PMID: 21060044.
5) Kleinerman RA,
Tucker MA,
Tarone RE,
Abramson DH,
Seddon JM,
Stovall M,
Li FP,
Fraumeni JF Jr.
Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up.
J Clin Oncol.
2005 Apr 1;23(10):2272-9.
PubMed PMID: 15800318.
6) Wong JR,
Morton LM,
Tucker MA,
Abramson DH,
Seddon JM,
Sampson JN,
Kleinerman RA.
Risk of subsequent malignant neoplasms in long-term hereditary retinoblastoma survivors after chemotherapy and radiotherapy.
J Clin Oncol.
2014 Oct 10;32(29):3284-90.
doi: 10.1200/JCO.2013.54.7844.
Epub 2014 Sep 2.
PubMed PMID: 25185089; PubMed Central PMCID: PMC4178525.
7) Marees T,
van Leeuwen FE,
de Boer MR,
Imhof SM,
Ringens PJ,
Moll AC.
Cancer mortality in long-term survivors of retinoblastoma.
Eur J Cancer.
2009 Dec;45(18):3245-53.
doi: 10.1016/j.ejca.2009.05.011.
Epub 2009 Jun 1.
PubMed PMID: 19493675.
8) Bracco S,
Leonini S,
De Francesco S,
Cioni S,
Gennari P,
Vallone IM,
Piu P,
Galimberti D,
Romano DG,
Caini M,
De Luca M,
Toti P,
Galluzzi P,
Hadjistilianou T,
Cerase A.
Intra-arterial chemotherapy with melphalan for intraocular retinoblastoma.
Br J Ophthalmol.
2013 Sep;97(9):1219-21.
doi: 10.1136/bjophthalmol-2013-303267.
Epub 2013 Jul 12.
PubMed PMID: 23853166.
9) Abruzzo TA,
Geller JI,
Kimbrough DA,
Michaels S,
Corrêa ZM,
Cornell K,
Augsburger JJ.
Adjunctive techniques for optimization of ocular hemodynamics in children undergoing ophthalmic artery infusion chemotherapy.
J Neurointerv Surg. 2015 Oct;7(10):770-6.
doi: 10.1136/neurintsurg-2014-011295.
Epub 2014 Sep 1.
PubMed PMID: 25179634.
10) Bertelli E,
Leonini S,
Galimberti D,
Moretti S,
Tinturini R,
Hadjistilianou T,
De Francesco S,
Romano DG,
Vallone IM,
Cioni S,
Gennari P,
Galluzzi P,
Grazzini I,
Rossi S,
Bracco S.
Hemodynamic and Anatomic Variations Require an Adaptable Approach during Intra-Arterial Chemotherapy for Intraocular Retinoblastoma: Alternative Routes,
Strategies,
and Follow-Up.
AJNR Am J Neuroradiol.
2016 Jul;37(7):1289-95.
doi: 10.3174/ajnr.A4741.
Epub 2016 Feb 25.
PubMed PMID: 26915566.
11) Klufas MA,
Gobin YP,
Marr B,
Brodie SE,
Dunkel IJ,
Abramson DH.
Intra-arterial chemotherapy as a treatment for intraocular retinoblastoma: alternatives to direct ophthalmic artery catheterization.
AJNR Am J Neuroradiol.
2012 Sep;33(8):1608-14.
doi: 10.3174/ajnr.A3019.
Epub 2012 Mar 22.
PubMed PMID: 22442047.
12) Suzuki S,
Yamane T,
Mohri M,
Kaneko A.
Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis.
Ophthalmology.
2011 Oct;118(10):2081-7.
doi: 10.1016/j.ophtha.2011.03.013.
Epub 2011 Jun 29.
PubMed PMID: 21715012.
13) http://www.eurosafeimaging.org/wp/wp-content/uploads/2015/09/Paediatric-imaging-WG_TipsTricks8_final.pdf
14) European Council Directive 2013/59/Euratom on basic safety standards for protection against the dangers arising from exposure to ionising radiation and repealing Directives 89/618/Euratom,
90/641/Euratom,
96/29/Euratom,
97/43/Euratom and 2003/122/Euratom.
OJ of the EU.
L13; 57: 1–73 (2014) 15) http://www.eurosafeimaging.org/wp/wp-content/uploads/2014/02/European-Guidelines-on-DRLs-for-Paediatric-Imaging_Revised_18-July-2016_clean.pdf
16) Boddu SR,
Abramson DH,
Marr BP,
Francis JH,
Gobin YP.
Selective ophthalmic artery chemosurgery (SOAC) for retinoblastoma: fluoroscopic time and radiation dose parameters.
A baseline study.
J Neurointerv Surg.
2017 Nov;9(11):1107-1112. doi: 10.1136/neurintsurg-2016-012758.
Epub 2016 Nov 9.
PubMed PMID: 29030462.
17) Bracco S,
Venturi C,
Leonini S,
Romano DG,
Cioni S,
Vallone IM,
Gennari P,
Hadjistilianou T,
De Francesco S,
Bertelli E.
Transorbital anastomotic pathways between the external and internal carotid systems in children affected by intraocular retinoblastoma.
Surg Radiol Anat.
2016 Jan;38(1):79-87.
doi: 10.1007/s00276-015-1519-3.
Epub 2015 Jul 22.
PubMed PMID: 26198114.
18) Cooke DL,
Stout CE,
Kim WT,
Hetts SW,
Higashida RT,
Halbach VV,
Dowd CF,
Gould RG.
Radiation dose reduction in intra-arterial chemotherapy infusion for intraocular retinoblastoma.
J Neurointerv Surg.
2014 Dec;6(10):785-9.
doi: 10.1136/neurintsurg-2013-010905.
Epub 2014 Jan 2.
PubMed
19) ICRP Statement on Tissue Reactions/Early and Late Effects of Radiation in Normal Tissues and Organs—Threshold Doses for Tissue Reactions in a Radiation Protection Context.
ICRP Publication 118.
Ann.
ICRP 41(1/2) 2012